Login / Signup

Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?

Marco UngariEnrico Pezzarossa
Published in: The American Journal of dermatopathology (2021)
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • adverse drug
  • emergency department
  • electronic health record